Chemoinformaics analysis of Malvidin-3-O-Beta-D-Glucoside
| Molecular Weight | 492.433 | nRot | 6 |
| Heavy Atom Molecular Weight | 468.241 | nRig | 24 |
| Exact Molecular Weight | 492.127 | nRing | 4 |
| Solubility: LogS | -3.548 | nHRing | 2 |
| Solubility: LogP | 0.191 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 16 |
| nHA | 12 | APOL | 64.037 |
| nHD | 6 | BPOL | 33.625 |
| QED | 0.271 |
| Synth | 4.186 |
| Natural Product Likeliness | 1.652 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.982 |
| HIA | 0.844 |
| CACO-2 | -6.092 |
| MDCK | 0.0000421 |
| BBB | 0.217 |
| PPB | 0.733839 |
| VDSS | 0.923 |
| FU | 0.227419 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.143 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.183 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.242 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.038 |
| CL | 6.079 |
| T12 | 0.661 |
| hERG | 0.058 |
| Ames | 0.665 |
| ROA | 0.026 |
| SkinSen | 0.024 |
| Carcinogencity | 0.042 |
| EI | 0.008 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.813 |
| Antiviral | Yes |
| Prediction | 0.887605 |